Financials TMS Co., Ltd.

Equities

4891

JP3544960002

Biotechnology & Medical Research

Market Closed - Japan Exchange 02:00:00 2024-06-10 am EDT 5-day change 1st Jan Change
211 JPY +3.94% Intraday chart for TMS Co., Ltd. +0.48% +12.23%

Valuation

Fiscal Period: February 2025 2026 2027
Capitalization 1 8,504 - -
Enterprise Value (EV) 1 8,504 8,504 8,504
P/E ratio -6.34 x -6.34 x -5.34 x
Yield - - -
Capitalization / Revenue - - 18.1 x
EV / Revenue - - 18.1 x
EV / EBITDA -6.72 x -6.59 x -5.59 x
EV / FCF -9.45 x -6.54 x -5.44 x
FCF Yield -10.6% -15.3% -18.4%
Price to Book - - -
Nbr of stocks (in thousands) 40,304 - -
Reference price 2 203.0 203.0 203.0
Announcement Date - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: February 2025 2026 2027
Net sales 1 - - 468.8
EBITDA 1 -1,265 -1,290 -1,521
EBIT 1 -1,275 -1,300 -1,531
Operating Margin - - -326.58%
Earnings before Tax (EBT) 1 -1,275 -1,300 -1,531
Net income 1 -1,275 -1,300 -1,531
Net margin - - -326.58%
EPS 2 -32.00 -32.00 -38.00
Free Cash Flow 1 -900 -1,300 -1,562
FCF margin - - -333.3%
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period:
Estimates

Balance Sheet Analysis

Fiscal Period: February 2025 2026 2027
Net Debt - - -
Net Cash position - - -
Leverage (Debt/EBITDA) - - -
Free Cash Flow 1 -900 -1,300 -1,563
ROE (net income / shareholders' equity) - - -
ROA (Net income/ Total Assets) - - -
Assets 1 - - -
Book Value Per Share - - -
Cash Flow per Share - - -
Capex 1 10 10 10
Capex / Sales - - 2.13%
Announcement Date - - -
1JPY in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
203 JPY
Average target price
760 JPY
Spread / Average Target
+274.38%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 4891 Stock
  4. Financials TMS Co., Ltd.